Investment Thesis
PETMED EXPRESS is in severe financial distress with a -39% net margin, negative operating cash flow of -$23.6M, and a critical liquidity crisis (0.89x current ratio). While modest YoY improvement in profitability shows some operational progress, the company remains deeply unprofitable with -$53M operating losses on $136M revenue, indicating fundamental business model challenges that threaten near-term viability.
Strengths
- No long-term debt minimizes financial leverage risk and restructuring complexity
- Net income and EPS improved 16-19% YoY demonstrating some operational progress toward profitability
- Gross margin of 26.6% proves core business model can be profitable with sufficient cost control or volume scaling
Risks
- Deeply unprofitable with -39% net margin and -39% operating margin indicating structural business model challenges
- Negative operating cash flow of -$23.6M and free cash flow of -$27.5M mean company is burning capital at unsustainable rates
- Critical liquidity crisis with current ratio of 0.89x and only $26.9M cash reserves relative to $27.5M annual cash burn
Key Metrics to Watch
- Operating cash flow trajectory - must turn positive to demonstrate business viability
- Operating margin progression - needs material improvement from -39% baseline to reach breakeven
- Cash burn rate and runway - critical given minimal cash buffer relative to operating losses
Financial Metrics
Revenue
136.2M
Net Income
-53.2M
EPS (Diluted)
$-2.55
Free Cash Flow
-27.5M
Total Assets
88.0M
Cash
26.9M
Profitability Ratios
Gross Margin
26.6%
Operating Margin
-38.9%
Net Margin
-39.1%
ROE
-162.4%
ROA
-60.5%
FCF Margin
-20.2%
Balance Sheet & Liquidity
Current Ratio
0.89x
Quick Ratio
0.66x
Debt/Equity
0.00x
Debt/Assets
62.8%
Interest Coverage
N/A
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-04-14T04:57:28.537788 |
Data as of: 2025-12-31 |
Powered by Claude AI